Form 4: Willis Towers Watson Executive Julie Jarecke Gebauer Reports Share Acquisition and Disposal

Julie Jarecke Gebauer, Head of Health, Wealth & Career at Willis Towers Watson, reports the acquisition of 4,213 ordinary shares and disposal of 72,786.886 ordinary shares on February 27, 2024.

Summary

• On February 27, 2024, Julie Jarecke Gebauer, Head of Health, Wealth & Career at Willis Towers Watson, reported transactions involving the company's ordinary shares.
• Gebauer acquired 4,213 ordinary shares at a price of $0 per share.
• Gebauer also disposed of 72,786.886 ordinary shares.
• Following these transactions, Gebauer directly owns 534 ordinary shares and indirectly owns 534 ordinary shares through the Dane Adam Gebauer Management Trust UA Feb 18, 2012 and 534 ordinary shares through the Jeffrey Austin Gebauer Management Trust UA Feb 18, 2012.
• The acquisition of 4,213 shares represents performance-based restricted share units earned based on the achievement of certain pre-established performance goals based on three-year annualized total shareholder return during the three-year performance period that ended on December 31, 2023.
• Each unit represents the right to receive one ordinary share of the Issuer upon the satisfaction of the service-based vesting requirement on July 20, 2024, subject to the terms of the award agreement.
• This number also includes the number of ordinary shares of the Issuer that are issuable pursuant to the dividend equivalent right under the terms of the award agreement providing for the accrual of dividends in the form of additional restricted share units that vest and are payable at the same time as the underlying performance-based restricted share units.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it is a standard regulatory filing detailing share transactions by an executive. The acquisition could be seen as slightly positive, while the disposal could be seen as slightly negative, balancing each other out.

Positives

• The acquisition of shares by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.

Negatives

• The disposal of 72,786.886 ordinary shares by a company executive could be interpreted negatively by investors.

Risks

• The vesting of the restricted share units is subject to the terms of the award agreement, which could include certain conditions that may not be met.
• Market conditions and company performance could impact the value of the shares acquired.

Future Outlook

The acquired shares will vest on July 20, 2024, subject to the terms of the award agreement.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. These transactions are closely monitored by regulators and investors for any potential signs of insider trading or other irregularities.

Comparison to Industry Standards

• Form 4 filings are standard practice for executives at publicly traded companies like Willis Towers Watson, similar to filings made by executives at competitors such as Aon and Marsh & McLennan.
• The reporting requirements are governed by Section 16(a) of the Securities Exchange Act of 1934, ensuring transparency in executive stock transactions across the industry.

Stakeholder Impact

• Shareholders may react to the reported transactions, potentially influencing the stock price.
• Employees may view the executive's share transactions as a reflection of the company's performance and future prospects.

Next Steps

• The acquired shares will vest on July 20, 2024, subject to the terms of the award agreement.

Key Dates